Score Your Stock

US stock · figures in US dollars · scored on full-year results

DaVita DaVita Inc. Common Stock

DVA · Healthcare · Medical Care Facilities
Top 43% of scored stocks
OkayTop 43% of scored stocks

DaVita scores 56/100 on fundamentals: in the top 43% of 503 scored S&P 500 stocks. Its strongest area is Risk (75/100); its weakest is Price Fairness (33/100).

Best
Risk 75
Weakest
Price 33

This stock is fairly balanced overall: price fairness is its weakest area.

What looks good
What to watch
Mkt capUS$ 11.9b#475 of 503 in the S&P 500EPSUS$ 11.84P/E12.9×✓ vs sector median 30.5×P/Bn/m (negative equity)Div yieldNo dividends paidBottom 12% in the S&P 50052w range · 59% of range101.00247.49
as of 31 Oct 2026

Nearby peers

Ranks #25 of 60 in Healthcare by score

#1Universal Health Services79#23Edwards Lifesciences57#24Zoetis57
#25DaVita56
#26Bristol Myers Squibb55#27Incyte55

One-Minute Summary

Why DaVita scores 56

This stock is fairly balanced overall: price fairness is its weakest area.

What looks good
What to watch

Business Strength

40
Why 40?
Pillar score: (0 + 1 + 2 + 1 + 0) = 4 of 10 points → 40
Return on Equity (ROE)n/m (negative equity)Weak4-Year Revenue Growth+5%/yrOkay4-Year Profit Growth+10%/yrStrongNet Profit Margin6%OkayQuarterly Momentum+6%Weak
Show 3 charts

Net Profit & Equity, with ROE

Net Profit ↑ +33.1%Equity ↓ -156%ROE % 773.2%
Net ProfitEquityROE %
692m936m747m920m1.1b121m-651m-591m202320242025TTM65.5%773.2%

Revenue & Net Profit, with Net Margin

Revenue ↑ +16.7%Net Profit ↑ +33.1%Net Margin % 6.5%
RevenueNet ProfitNet Margin %
12.1b12.8b13.6b14.2b692m936m747m920m202320242025TTM5.7%7.3%5.5%6.5%

Sales grew about 16.7% over 4 years: customers keep spending more with this company.

Profit climbed about 33.1% over 4 years: the business keeps more money as it grows.

Recent Quarters: Revenue & Net Profit (the last 8 quarters, scored)

Revenue ↑ +8.9%Net Profit ↑ +23.6%Net Margin % 7.5%
RevenueNet ProfitNet Margin %
3.3b3.3b3.2b3.4b3.4b3.6b3.4b3.6b215m574m163m199m150m234m198m265mQ3'24Q4'24Q1'25Q2'25Q3'25Q4'25Q1'26Q2'266.6%17.4%5.1%5.9%4.4%6.5%5.8%7.5%
▼▲▼▼▼▼▲▲

Sales grew about 8.9% over the last 8 quarters: customers keep spending more with this company.

Profit grew about 23.6% over the last 8 quarters: the business is keeping more of what it earns.

Why 67?
Pillar score: (2 + 1 + 1) = 4 of 6 points → 67
Debt-to-Equity-22.7×StrongCurrent Ratio1.4×OkayInterest Coverage3.6×Okay
Show 2 charts

Debt vs Equity, with D/E ratio

Total Debt ↑ +20.5%Equity ↓ -156%D/E 99.6×
Total DebtEquityD/E
11.1b12.1b12.9b13.4b1.1b121m-651m-591m202320242025TTM10.5×99.6×

Borrowings grew about 20.5% over 4 years: watch this; rising debt adds pressure in bad times.

Short-term assets vs bills, with Current Ratio

Current Assets ↑ +29.9%Current Liabilities ↑ +9.3%Current Ratio 1.4×
Current AssetsCurrent LiabilitiesCurrent Ratio
3.1b3.7b4.1b4.1b2.6b3.0b3.1b2.9b202320242025TTM1.2×1.3×1.3×1.4×
Why 63?
Pillar score: (0 + 1 + 2 + 2) = 5 of 8 points → 63
Dividend QualityNo dividends paidWeak
Payout ratio: 0%
Operating Cash FlowPositive but bumpyOkayFree Cash FlowPositive & growingStrongCash & Cash EquivalentsGrowing & covers near-term debtStrong
Show 3 charts

Operating vs Free Cash Flow

Operating CF ↓ -9.2%Free CF ↓ -13.2%
Operating CFFree CF
2.1b2.0b1.9b1.9b1.5b1.5b1.3b1.3b202320242025TTM

Cash keeps coming in, though unevenly: fine, but worth keeping an eye on.

Cash vs Total Debt

Cash ↑ +30.4%Short-Term Debt ↓ -8.8%Total Debt ↑ +20.5%
CashShort-Term DebtTotal Debt
380m795m676m496m123m271m109m113m11.1b12.1b12.9b13.4b202320242025TTM

Dividends per Share, with Yield

DPS (cents) → +0%Yield % 0%
DPS (cents)Yield %
000020222023202420250%0%0%0%

Dividends per share have been maintained or raised: management shares the rewards with you.

Why 33?
Pillar score: (1 + 0 + 1) = 2 of 6 points → 33
P/E Ratio12.9×OkayP/B Ration/m (negative equity)WeakPEG Ratio1.3Okay
Show chart

Share Price: Weekly Closes (not part of the score)

US$ 240.09US$ 172.41US$ 104.74Oct '25Feb '26Jun '26Oct '26

The share price is up about 57.5% over the past year.

Why 75?
Pillar score: (2 + 0 + 2 + 2 + 2 + 1) = 9 of 12 points → 75
Earnings ConsistencySteadyStrongDebt Trend (4yr)RisingWeakShare Count Trend (4yr)-11%/yrStrongInventory vs Sales (4yr)-1.2 pp/yr vs salesStrongAsset Turnover Trend (4yr)+10.7%StrongQuarterly Consistency2 of 4 quarters downOkay
Show chart

Revenue vs Inventory, with Inventory % of Revenue

Revenue ↑ +16.7%Inventory ↑ +12.9%Inv. % of Rev. 1.1%
RevenueInventoryInv. % of Rev.
12.1b12.8b13.6b14.2b143m135m161m162m202320242025TTM1.2%1.1%1.2%1.1%
Ranks #25 of 60 in Healthcare by score

Sector peers

#1Universal Health Services79#23Edwards Lifesciences57#24Zoetis57
#25DaVita (you)56
#26Bristol Myers Squibb55#27Incyte55

Full Financial History

Every reported figure behind the score, year by year. Download it, or check it against the company's own annual report.

Financial YearRevenueNet ProfitOperating Cash FlowFree Cash FlowCapExCashTotal DebtShort-Term DebtEquityCurrent AssetsCurrent LiabilitiesTotal AssetsTotal LiabilitiesInventoryDividendsReturn on Equity (ROE)Net Profit MarginDebt-to-EquityCurrent RatioInterest CoverageDiv yieldP/E RatioP/B RatioPEG Ratio
2026US$ 14.2bUS$ 920.1mUS$ 1.9bUS$ 1.3bUS$ -576.8mUS$ 495.6mUS$ 13.4bUS$ 112.5mUS$ -591.1mUS$ 4.1bUS$ 2.9bUS$ 17.8bUS$ 16.7bUS$ 161.5m--156%6%-22.7×1.4×3.6×----
2025US$ 13.6bUS$ 746.8mUS$ 1.9bUS$ 1.3bUS$ -575.9mUS$ 676.4mUS$ 12.9bUS$ 109.2mUS$ -651.1mUS$ 4.1bUS$ 3.1bUS$ 17.5bUS$ 16.3bUS$ 160.6mUS$ 0.0m-115%5%-19.8×1.3×3.3×0%10.5×-12.1×1.1
2024US$ 12.8bUS$ 936.3mUS$ 2.0bUS$ 1.5bUS$ -555.4mUS$ 794.9mUS$ 12.1bUS$ 270.9mUS$ 121.1mUS$ 3.7bUS$ 3.0bUS$ 17.3bUS$ 15.2bUS$ 134.6mUS$ 0.0m773%7%99.6×1.3×4.3×0%13.1×101.6×-
2023US$ 12.1bUS$ 691.5mUS$ 2.1bUS$ 1.5bUS$ -568.0mUS$ 380.1mUS$ 11.1bUS$ 123.3mUS$ 1.1bUS$ 3.1bUS$ 2.6bUS$ 16.9bUS$ 14.2bUS$ 143.1mUS$ 0.0m65%6%10.5×1.2×4.0×0%13.5×8.8×-